Table 3.
Baseline characteristics of olive-allergic patients.
| Clinical and demographic characteristics | All patients n = 281 (%) | |||
|---|---|---|---|---|
| Gender | ||||
| Male | 139 (49.5) | |||
| Female | 142 (50.5) | |||
| Skin tests | ||||
| Grass positive | 84 (32.6) | |||
| Olive positive | 252 (97.7) | |||
| Profilin positive | 19 (7.4) | |||
| Polcalcin positive | 18 (8.1) | |||
| Allergy symptoms | ||||
| Rhinoconjunctivitis | ||||
| No | 2 (0.7) | |||
| Mild | 123 (43.8) | |||
| Moderate/severe | 156 (55.5) | |||
| Asthma | ||||
| No | 26 (9.3) | |||
| Mild | 135 (48.0) | |||
| Moderate-severe | 120 (42.7) | |||
| Immunotherapy | ||||
| No | 173 (61.6) | |||
| Olive immunotherapy | 108 (38.4) | |||
| Mean | Median | SD* | IQR† | |
| Age | 22.8 | 21.0 | 13.2 | 13.0–32.5 |
| Total IgE (kU/L) | 646.1 | 326.0 | 834.0 | 135.0–757.0 |
| Olea sIgE‡ (kUA/L) | 88.7 | 38.9 | 122.3 | 12.9–99.9 |
| Ole e 1 sIgE (kUA/L) | 55.5 | 16.6 | 100.5 | 4.3–55.9 |
| Ole e 7 sIgE (kUA/L) | 44.7 | 7.6 | 82.4 | 0.4–57.4 |
| Ole e 9 sIgE (kUA/L) | 20.3 | 0.0 | 54.1 | 0.0–11.0 |
SD*, standard deviation; IQR†, interquartile range; sIgE‡, specific Immunoglobulin E.